Ever Source Wealth Advisors, LLC Nuvation Bio Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 11,424 shares of NUVB stock, worth $22,162. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,424
Previous 11,095
2.97%
Holding current value
$22,162
Previous $25,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NUVB
# of Institutions
163Shares Held
150MCall Options Held
1.2KPut Options Held
223K-
Decheng Capital LLC Menlo Park, CA26MShares$50.4 Million14.81% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$31.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.7MShares$30.5 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$25.4 Million53.05% of portfolio
-
Octagon Capital Advisors LP New York, NY9.2MShares$17.9 Million5.46% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $421M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...